IRIS UniCatt

Bria, Pietro
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 5.710
NA - Nord America 5.245
AS - Asia 3.625
SA - Sud America 710
AF - Africa 86
OC - Oceania 30
Continente sconosciuto - Info sul continente non disponibili 7
Totale 15.413
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.113
DE - Germania 2.153
SG - Singapore 1.746
CN - Cina 1.094
IT - Italia 805
SE - Svezia 730
UA - Ucraina 601
BR - Brasile 598
FR - Francia 437
GB - Regno Unito 292
IE - Irlanda 200
VN - Vietnam 161
FI - Finlandia 137
IN - India 134
ID - Indonesia 131
RU - Federazione Russa 120
PL - Polonia 61
CA - Canada 58
TR - Turchia 56
MX - Messico 51
BD - Bangladesh 50
AR - Argentina 43
JP - Giappone 43
NL - Olanda 38
AU - Australia 29
HK - Hong Kong 29
BE - Belgio 26
ES - Italia 23
CI - Costa d'Avorio 22
IQ - Iraq 20
ZA - Sudafrica 19
IR - Iran 18
KR - Corea 18
CH - Svizzera 13
PY - Paraguay 13
SA - Arabia Saudita 13
VE - Venezuela 13
AT - Austria 12
EC - Ecuador 12
MA - Marocco 12
IL - Israele 11
LT - Lituania 11
EG - Egitto 10
AZ - Azerbaigian 9
CL - Cile 9
PE - Perù 9
PK - Pakistan 9
UZ - Uzbekistan 9
AE - Emirati Arabi Uniti 8
TW - Taiwan 8
CO - Colombia 7
JO - Giordania 7
LB - Libano 7
BG - Bulgaria 6
BY - Bielorussia 6
TN - Tunisia 6
CZ - Repubblica Ceca 5
DZ - Algeria 5
HU - Ungheria 5
KE - Kenya 5
KZ - Kazakistan 5
NO - Norvegia 5
RO - Romania 5
AL - Albania 4
LK - Sri Lanka 4
NP - Nepal 4
OM - Oman 4
PA - Panama 4
PH - Filippine 4
TH - Thailandia 4
TT - Trinidad e Tobago 4
UY - Uruguay 4
A1 - Anonimo 3
CR - Costa Rica 3
DO - Repubblica Dominicana 3
JM - Giamaica 3
KG - Kirghizistan 3
LA - Repubblica Popolare Democratica del Laos 3
MY - Malesia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AM - Armenia 2
AO - Angola 2
BB - Barbados 2
ET - Etiopia 2
EU - Europa 2
GR - Grecia 2
HR - Croazia 2
LV - Lettonia 2
MC - Monaco 2
PS - Palestinian Territory 2
RS - Serbia 2
SY - Repubblica araba siriana 2
AD - Andorra 1
GE - Georgia 1
GM - Gambi 1
GY - Guiana 1
HN - Honduras 1
IS - Islanda 1
KY - Cayman, isole 1
LU - Lussemburgo 1
Totale 15.402
Salva come PNG Salva come JPEG
Città #
Chandler 861
Singapore 859
Ashburn 515
Jacksonville 330
San Mateo 245
Dublin 196
Nanjing 183
Beijing 173
Milan 169
Wilmington 157
Nürnberg 124
Dearborn 120
Jakarta 120
Woodbridge 119
New York 111
Los Angeles 110
Bremen 106
Rome 102
Houston 96
Hefei 91
Redwood City 90
Boston 85
Ann Arbor 77
Nanchang 77
Seattle 73
Lawrence 68
Moscow 68
Ho Chi Minh City 59
São Paulo 57
Munich 54
University Park 53
Frankfurt am Main 51
Princeton 48
Marseille 47
Norwalk 46
Mountain View 44
Hanoi 43
Lancaster 40
Fairfield 36
Buffalo 34
Hebei 33
Kent 32
Cattolica 31
Dallas 30
Guangzhou 30
Kunming 30
Paris 28
Shenyang 28
Boardman 27
Shanghai 27
Tianjin 27
Cambridge 26
Fremont 26
Hangzhou 25
Hong Kong 25
Izmir 25
Tokyo 24
Warsaw 24
Brooklyn 23
Abidjan 22
Changsha 22
Falls Church 22
Kraków 22
Columbus 21
Andover 20
Düsseldorf 20
Rio de Janeiro 20
Brussels 19
Philadelphia 19
Atlanta 18
Bologna 18
Chennai 17
Helsinki 17
Menlo Park 17
Porto Alegre 17
Jiaxing 16
Belo Horizonte 15
Chicago 15
London 15
Mexico City 15
Pune 15
Montreal 14
Brasília 13
Saint-Ouen-l'Aumone 13
Stockholm 13
Bexley 12
Detroit 12
Portsmouth 12
Sydney 12
Augusta 11
Santa Clara 11
The Dalles 11
Baghdad 10
Bragança 10
Johannesburg 10
Kish 10
Lanzhou 10
Leawood 10
Phoenix 10
Simi Valley 10
Totale 7.074
Salva come PNG Salva come JPEG
Nome #
Plasma cortisol levels and resilience in depressed patients 244
Pregabalin versus naltrexone in alcohol dependence: a randomised, double-blind, comparison trial 242
Alterazioni delle risposte immuno-infiammatorie nei pazienti affetti da disturbo depressivo maggiore (Immune-inflammatory response changes in patients with major depressive disorder) 240
Behavioural addictions in bipolar disorder patients: Role of impulsivity and personality dimensions 240
Programma di trattamento integrato in regime di day hospital per pazienti depressi “difficili” da trattare. 239
Pregabalin, tiapride and lorazepam in alcohol withdrawal syndrome: a multi-centre, randomized, single-blind comparison trial. 233
Cognitive markers of psychotic unipolar depression: A meta-analytic study 225
Bipolar Disorder Questionnaire for the Assessment of Learning: a New Instrument for Studying Information Acquisition in Psychoeducational programs. 220
Neuroendocrinologia dei disturbi dell umore 206
Augmentation of drug treatment with bright light therapy in patients with difficult-to-treat depression: acute and long term observation 197
Plasma magnesium level and psychomotor retardation in major depressed patients 194
Dopamine transporter availability and psychomotor retardation in major depression 194
Bipolar disorder: "pure" versus mixed depression over a 1-year follow-up. 185
[Diagnosis of deficit and attention/hyperactivity disorders (ADHD) in patients with bipolar or unipolar depression: an experimental study] 184
Predicting treatment outcome in difficult-to-treat depressed patients 181
Modulation of motor cortex neuronal networks by rTMS: comparison of local and remote effects of six different protocols of stimulation 181
Bipolar disorder: "pure" versus mixed depression over a 1-year follow-up 174
Striatal dopamine transporter (DAT) availability and affective symptoms in movement disorders: a 123I-FP-CIT SPECT study. 170
Role of Substance Abuse Comorbidity and Personality on the Outcome of Depression in Bipolar Disorder: Harm Avoidance Influences Medium-Term Treatment Outcome. 169
Problematic mobile phone use in adolescence: A cross-sectional study 169
A day treatment programme on mood disorders: One-year activity outcomes 168
Sexual Behavior in Women with Bipolar Disorder 166
Non-Epileptic Seizures (NES) are predicted by depressive and dissociative symptoms 165
[Diagnosis of deficit and attention/hyperactivity disorders (ADHD) in patients with bipolar or unipolar depression: an experimental study]. 164
Plasma magnesium levels and treatment outcome in depressed patients 163
Correlations Between Striatal Dopamine Transporter (DAT) Availability and Psychiatric Symptoms in Movement Disorders: A 123I-FP-CIT SPECT Study. 159
Treatment of prurigo nodularis with pregabalin. 159
Bipolar disorder: "pure" versus mixed depression over a 1-year follow-up 156
Internet addiction: hours spent online, behaviors and psychological symptoms 155
An observational study evaluating comorbidity between bipolar disorder and personality disorders 152
Factors associated with the course of symptoms in bipolar disorder during a 1-year follow-up: depression vs. sub-threshold mixed state 149
Plasma magnesium levels and treatment outcome in depressed patients 147
Polysomnographic Findings in a Cohort of Chronic Insomnia Patients with Benzodiazepines Abuse 147
Changing of dopamine transporter binding in depressed patients with anhedonia during treatment 146
Anhedonia and Cortisol Levels in Major Depression. 145
Cognitive markers of psychotic unipolar depression: A meta-analytic study 145
Role of substance abuse comorbidity and personality on the outcome of depression in bipolar disorder: harm avoidance influences medium-term treatment outcome 144
Alcohol protracted withdrawal syndrome: the role of anhedonia 144
Changes of Dopamine Transporter Availability in Depressed Patients with and without Anhedonia: A 123I-N-ω-Fluoropropyl-Carbomethoxy-3β-(4-Iodophenyl)tropane SPECT Study 144
Pregabalin in outpatient detoxification of subjects with mild-to-moderate alcohol withdrawal syndrome. 141
Clinical features, response to treatment and functional outcome of bipolar disorder patients with and without co-occurring substance use disorder: 1-year follow-up 141
Behavioural addictions in adolescents and young adults: results from a prevalence study. 139
Affective temperaments and psychopathological dimensions of personality in bipolar and cyclothymic patients 139
Il trattamento della schizofrenia 137
Hyperactivation of inflammatory response in depressed patients with psychomotor retardation 134
Psicopatologia nell’epilessia e nella pseudoepilessia: risultati preliminari nella nostra esperienza 134
Affective temperament and attachment in adulthood in patients with Bipolar Disorder and Cyclothymia 134
Affective temperaments and psychopathological dimensions of personality in Bipolar Disorder 132
Clinical correlates of difficult-to-treat depression: Exploring an integrated day-care model of treatment 132
Augmentation of light therapy in difficult-to-treat depressed patients: an open-label trial in both unipolar and bipolar patients 131
Predictive value of magnesium levels in depressed patients. 130
Treatment of prurigo nodularis with pregabalin 129
Striatal dopamine transporter density in anhedonic depressed patients before and after pharmachological treatment 129
What is the effect of selective serotonin reuptake inhibitors on temperament and character in patients with fibromyalgia? 128
Somatic symptoms and high-sensitive C-reactive protein in major depression 128
The assessment of post-detoxification anhedonia: influence of clinical and psychosocial variables 127
Duloxetine for premenstrual dysphoric disorder: a pilot study 126
SNRI effective treatment does not restore changes of immune and inflammatory parameters in depressed patients 126
Plasma dehydroepiandrosterone sulphate (DHEAS) and cortisol in patients with mood disorders 126
Facial emotion recognition deficit in Amnestic Mild Cognitive Impairment and Alzheimer Disease 124
Inflammatory response and psychopathological dimensions in major depression 123
Depression and suicide in epilepsy: Fact or artefact? 122
Mood, hormones and quality of life. 122
Analisi antropofenomenologica di un'esperienza in un'istituzione manicomiale del meridione 120
La gestione della crisi suicidaria: dall'emergenza clinica alla riabilitazione del paziente 120
Omega-3 fatty acids and antioxidants in neurological and psychiatric diseases: an overview 119
Enhanced BDNF serum levels in patients with severe pathological gambling 118
Omega-3 fatty acids and antioxidants in neurological and psychiatric diseases: an overview. 118
Major depressive disorder and dopamine transporter density: investigation by 123I-FP-CIT SPET 118
Reduced serum concentrations of nerve growth factor, but not brain-derived neurotrophic factor, in chronic cannabis abusers 117
Oxcarbazepine in bipolar disorder: a critical review of the literature 116
Behavioural addictions in adolescents and young adults: results from a prevalence study 115
Cocaine addiction: from habits to stereotypical-repetitive behaviors and punding 114
Plasma levels of n-3 fatty acids in bipolar patients: Deficit restricted to DHA 114
Ansia, depressione ed epilessia del lobo temporale 113
Neuroendocrinology of mood disorders. 113
Venlafaxine: Successful treatment in impulsive disorders 113
Ginkgo biloba and donepezil: a comparison in the treatment of Alzheimer's dementia in a randomized placebo-controlled double-blind study. 113
Evidenze preliminari sulle modifiche del transporter della dopamina in pazienti depressi con rallentamento psicomotorio 113
Oxcarbazepine improves mood in patients with epilepsy. 110
Oxcarbazepine improves mood in patients with epilepsy 110
Cocaine use disorders and serum magnesium profile 110
Omega-3 fatty acids and antioxidants in neurological and psychiatric diseases: An overview. 110
Sleep Disturbances and Depression: a review 108
Effects of psychostimulants on neurotrophins implications for psychostimulant-induced neurotoxicity. 106
Chronic ketamine use increases serum levels of brain-derived neurotrophic factor. 105
Reply to Dr Korczyn. 103
Antidepressant treatment restores brain-derived neurotrophic factor serum levels and ameliorates motor function in Parkinson disease patients 103
Reply to Dr Corrao and colleagues. 102
Enhanced BDNF serum levels in patients with severe pathological gambling 101
DAT binding and psychopathological features in depressed patients. 100
Primary cerebral blood flow deficiency and Alzheimer's disease: shadows and lights. 99
Functional neuroimaging: points of intersection between biology and psychotherapy. 98
To be or not to be a bipolar disorder patient: problems with diagnosis. 98
Bipolar disorder and epilepsy: a bidirectional relation? Neurobiological underpinnings, current hypotheses, and future research directions 96
Relating with migrants: ethnopsychiatry and psychotherapy 95
Ecstasy (MDMA)-addicted subjects show increased serum levels of brain-derived neurotrophic factor, independently from a rise of drug-induced psychotic symptoms 95
Effect of aripiprazole on self-reported anhedonia in bipolar depressed patients 94
Il self-help nelle condizioni depressive: analisi dell esperienza di un gruppo di mutuo-aiuto per pazienti depressi in remissione parziale. 93
Paliperidone for treatment of obsessive compulsive resistant symptoms in schizophrenia: a case report. 92
Totale 14.121
Salva come PNG Salva come JPEG
Categoria #
all - tutte 56.904
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 56.904
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021741 0 0 0 0 0 67 231 16 137 92 178 20
2021/20221.102 109 135 19 61 40 26 34 193 40 70 169 206
2022/20232.407 297 362 160 409 196 273 121 161 297 22 74 35
2023/20241.003 48 303 23 44 37 112 42 34 35 51 154 120
2024/20252.265 120 108 159 117 208 90 49 149 351 189 388 337
2025/20262.912 807 132 290 540 985 158 0 0 0 0 0 0
Totale 15.472